- Home
- GEHC vs CBOE Comparison
GEHC vs CBOE Comparison
Compare GEHC & CBOE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GEHC | CBOE |
|---|---|---|
| Founded | 1892 | 1973 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Investment Bankers/Brokers/Service |
| Sector | Technology | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.9B | 25.6B |
| IPO Year | 2022 | 2010 |
Fundamental Metrics
Financial Performance| Metric | GEHC | CBOE |
|---|---|---|
| Price | $65.22 | $277.71 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 13 | 9 |
| Target Price | $88.38 | ★ $289.44 |
| AVG Volume (30 Days) | ★ 4.5M | 1.7M |
| Earning Date | 04-29-2026 | 05-01-2026 |
| Dividend Yield | 0.24% | ★ 0.94% |
| EPS Growth | 4.84 | ★ 44.52 |
| EPS | 0.85 | ★ 3.66 |
| Revenue | ★ $20,625,000,000.00 | $2,229,100,000.00 |
| Revenue This Year | $7.12 | N/A |
| Revenue Next Year | $4.45 | $3.54 |
| P/E Ratio | $77.12 | ★ $75.61 |
| Revenue Growth | 4.84 | ★ 239.31 |
| 52 Week Low | $58.75 | $227.15 |
| 52 Week High | $89.77 | $371.18 |
Technical Indicators
Market Signals| Indicator | GEHC | CBOE |
|---|---|---|
| Relative Strength Index (RSI) | 54.59 | 53.36 |
| Support Level | $60.08 | $274.41 |
| Resistance Level | $65.72 | $279.33 |
| Average True Range (ATR) | 1.76 | 10.81 |
| MACD | -0.04 | 5.73 |
| Stochastic Oscillator | 84.88 | 89.02 |
Price Performance
Historical ComparisonAbout GEHC GE HealthCare Technologies Inc.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
About CBOE Cboe Global Markets Inc.
Founded in 1973, Cboe controls the largest option exchange in the US, which provides around 60% of the firm's revenue. The company is best known for its proprietary S&P 500 and VIX index options, which it offers through an exclusive contract with S&P Global. The firm moved into US and European equities through the $3.4 billion acquisition of BATS in 2017. Cboe has continued to look to expand internationally, using acquisitions to build a presence in both Canada and Australia.